UFP Technologies, Inc. (UFPT)
295.78
-1.55
(-0.52%)
USD |
NASDAQ |
Oct 23, 16:00
305.19
+9.41
(+3.18%)
After-Hours: 20:00
UFP Technologies Enterprise Value : 2.418B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.418B |
| October 22, 2026 | 2.430B |
| October 21, 2026 | 2.374B |
| October 20, 2026 | 2.384B |
| October 19, 2026 | 2.399B |
| October 16, 2026 | 2.387B |
| October 15, 2026 | 2.429B |
| October 14, 2026 | 2.382B |
| October 13, 2026 | 2.407B |
| October 12, 2026 | 2.419B |
| October 09, 2026 | 2.366B |
| October 08, 2026 | 2.347B |
| October 07, 2026 | 2.396B |
| October 06, 2026 | 2.473B |
| October 05, 2026 | 2.508B |
| October 02, 2026 | 2.456B |
| October 01, 2026 | 2.412B |
| September 30, 2026 | 2.426B |
| September 29, 2026 | 2.427B |
| September 28, 2026 | 2.445B |
| September 25, 2026 | 2.417B |
| September 24, 2026 | 2.439B |
| September 23, 2026 | 2.353B |
| September 22, 2026 | 2.336B |
| September 21, 2026 | 2.309B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.270B |
| September 17, 2026 | 2.261B |
| September 16, 2026 | 2.292B |
| September 15, 2026 | 2.261B |
| September 14, 2026 | 2.281B |
| September 11, 2026 | 2.280B |
| September 10, 2026 | 2.276B |
| September 09, 2026 | 2.285B |
| September 08, 2026 | 2.305B |
| September 04, 2026 | 2.364B |
| September 03, 2026 | 2.347B |
| September 02, 2026 | 2.392B |
| September 01, 2026 | 2.405B |
| August 31, 2026 | 2.435B |
| August 28, 2026 | 2.451B |
| August 27, 2026 | 2.451B |
| August 26, 2026 | 2.486B |
| August 25, 2026 | 2.484B |
| August 24, 2026 | 2.493B |
| August 21, 2026 | 2.522B |
| August 20, 2026 | 2.484B |
| August 19, 2026 | 2.550B |
| August 18, 2026 | 2.559B |
| August 17, 2026 | 2.616B |
| August 14, 2026 | 2.620B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.45B |
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.85M |
| Revenue (Quarterly) | 173.96M |
| Total Expenses (Quarterly) | 153.11M |
| EPS Diluted (Quarterly) | 2.677 |
| Gross Profit Margin (Quarterly) | 29.27% |
| Profit Margin (Quarterly) | 11.99% |
| Earnings Yield | 3.14% |
| Operating Earnings Yield | 4.17% |
| Normalized Earnings Yield | 3.131 |